‌

US Patent 10253067 Peptidomimetic macrocycles and uses thereof

Patent 10253067 was granted and assigned to Aileron Therapeutics on April, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Aileron Therapeutics

Current Assignee

Aileron Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10253067

Patent Inventor Names

Yong Chang1

Hubert Chen1

Karen Olson1

Manuel Aivado1

Chris Viau1

David Allen Annis1

Date of Patent

April 9, 2019

Patent Application Number

15074794

Date Filed

March 18, 2016

Patent Primary Examiner

‌

Marcela M Cordero Garcia

Patent abstract

Methods for treating liquid cancer, determined to lack a p53 deactivation mutation, in a subject are provided. Also provided are peptidomimetic macrocycles for use in treatment of a liquid cancer, determined to lack a p53 deactivation mutation, in a subject.